Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion
Author(s) -
Sudha Mannava,
Kalyana Moparthy,
Linda J. Wheeler,
Katerina I. Leonova,
Joseph A. Wawrzyniak,
Anna Bianchi,
A. E. Berman,
Sheryl A. Flanagan,
Donna S. Shewach,
Nathalie C. Zeitouni,
Andrei V. Gudkov,
Christopher K. Mathews,
Mikhail A. Nikiforov
Publication year - 2012
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.100512
Subject(s) - ribonucleotide reductase , senescence , dna damage , thymidylate synthase , dna , biology , microbiology and biotechnology , cancer research , phenotype , chemistry , biochemistry , cancer , gene , genetics , protein subunit , fluorouracil
The down-regulation of dominant oncogenes, including C-MYC, in tumor cells often leads to the induction of senescence via mechanisms that are not completely identified. In the current study, we demonstrate that MYC-depleted melanoma cells undergo extensive DNA damage that is caused by the underexpression of thymidylate synthase (TS) and ribonucleotide reductase (RR) and subsequent depletion of deoxyribonucleoside triphosphate pools. Simultaneous genetic inhibition of TS and RR in melanoma cells induced DNA damage and senescence phenotypes very similar to the ones caused by MYC-depletion. Reciprocally, overexpression of TS and RR in melanoma cells or addition of deoxyribo-nucleosides to culture media substantially inhibited DNA damage and senescence-associated phenotypes caused by C-MYC depletion. Our data demonstrate the essential role of TS and RR in C-MYC-dependent suppression of senescence in melanoma cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom